This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Trauma patients administered oral THC consume fewer opioids than do similarly matched controls, according to clinicaltrialdata published in the journal Trauma Surgery & Acute Care.
The administration of oral CBD reduces cue-induced cravings and anxiety in subjects with a history of heroin use, according to clinicaldata published in The American Journal of Psychiatry. Additional information is available in NORML’s fact-sheet , “Relationship between marijuana and opioids.”
The call for comments, posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”
Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.
Researchers studying the efficacy of marijuana treatments for veterans’ mental health now have access to $20 million in marijuana tax revenue to fund clinicaltrials. The Marijuana Regulatory Agency issued a request for proposals for the 2021 Veteran Marijuana Research Grant Program on Tuesday, June 1.
Federal regulators have approved two clinical studies testing whether a marijuana-based epilepsy drug may help prevent seizures among epileptic children. Thus, the regulator plans to take the drug on a case-by-case basis, leaving the marijuana-derivative unapproved for general clinical prescriptive use.
Not only this, but Gaize recently completed the largest clinicaltrial into cannabis impairment , and the results are set to transform the realm of workplace and road safety. Keen to learn more about the trial and Gaize’s innovative product, I asked CEO Ken Fichtler some questions. Here’s what he had to say.
Clinicaltrials into cannabis’ potential as an opioid replacement are well underway in South Africa. We are currently recruiting patients, and data-capturing all the questionnaires and feedback from the patients for the live study. Quite frankly, the clinicaltrials couldn’t have come at a better time.
New research suggests compounds in marijuana may protect the brain from damage following a stroke. Scientists hope to perform human trials in the near future. The data are guiding the next steps in experimental stroke in order to be able to progress onto initial safety assessments in a clinicaltrial.”.
The supportive regulatory environment has facilitated a mounting body of clinical and transnational research demonstrating the efficacy of medically prescribed marijuana. The suffering of these patients is heartwrenching; their plight has elicited public outrage and galvanized multipartisan support for medical marijuana.
Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced positive topline data from the PACIFIC Study evaluating bexicaserin (LP352), a potentially best-in-class and highly. Read More
A recent study , funded by the National Institute on Drug Abuse (NIDA) and published in JAMA Network Open , reported a correlation between obtaining a medical marijuana (MMJ) card and developing CUD. Kevin Potter taking responsibility for the integrity and accuracy of the data. ClinicalTrial Sample Size.
The people of Japan, a country renowned for its sushi cuisine scene, iconic Mount Fuji, and eye-catching cherry blossom trees, may soon have access to legal medicinal marijuana for intractable diseases. 124’—the use and application of medicines manufactured from “marijuana” to any person are currently prohibited.
Clinicaltrials involving psychedelic drugs and substances are, however, permitted, provided they comply with both state and federal laws applicable to such trials. states that have legalized marijuana for therapeutic or adult-use, which is currently illegal under U.S. federal law.
Even though scientific data is still somewhat scarce on this topic, several studies confirm that cannabis directly acts on the cells of the immune system affected by HIV. The research showed that those who used marijuana had a lower amount of the virus in their blood compared to those who didn’t use marijuana. 2016 ( 3 ).
The country, which Tilray said has an estimated medical marijuana demand of more than 100,000 patients, legalized the drug for medical use in 2017 but has since relied on importing it. We do believe that there is an important role for clinicaltrials to play in terms of establishing the efficacy of the product,” Faltischek said. “We
Inhaling marijuana is associated with reductions in headache and migraine severity, according to a new study published in the Journal of Pain , and published by the National Institute of Health. The post Study: Inhaling Marijuana Associated With Reductions in Headache/Migraine Severity appeared first on TheJointBlog.
Of course, legalization and education efforts can only go so far without data, and that’s where RoC’s research initiatives come into play. RoC’s research efforts have already resulted in an enlightening report that revealed a number of specific health improvements among cannabis users versus non-users, warranting clinicaltrials.
HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. THC is considered “marijuana” or “cannabis.” increase in annual sales.
Are you able to answer your patients’ medical marijuana questions? During my tenure, I have found the medical marijuana educational gap to be one of the most significant educational gaps that impacts a very broad range of healthcare providers. million medical marijuana patients nationwide.
MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. Tim Moynahan the company chairman stated that “Patients in the MMJ International holdings clinicaltrials will receiv e gelatin capsules containing THC and CBD daily.”.
The paper concluded that the “lack of a dominant narrative environment” on the efficacy of medical marijuana can represent a barrier to the implementation of medical cannabis policies. A nationwide survey carried out in 2017 found that only 9% of medical schools have medical marijuana documented in their curriculum, and that 66.7%
The data from this study is promising and reveals that CBD worked to inhibit the spread of a virus in human lung cell samples, which is huge news. However, it warrants further examination and exploration by science in the form of clinicaltrials, which is what many in the scientific community are calling for.
Marijuana may be use “in the treatment of a range of psychiatric disorders”, according to a new study published in the journal BMC Psychiatry. The study is titled “Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.”
If you carefully analyze all of the states that have approved medical marijuana, you may notice a pattern among all the qualifying conditions these states list. The two active cannabinoids in marijuana are cannabidiol (CBD) and tetrahydrocannabinol (THC), the latter of which causes psychoactive effects while the former does not.
Miss Marijuana will break it down for you Bill Nye style so you can get back to your regularly scheduled program or go buy some CBD products! . The post New Study On CBD And Sleep Shows Promising Results appeared first on Miss Marijuana. So what exactly did researchers at CAHS find? Our health and wellness depends on it!
According to a newly released study that will come as no surprise to marijuana consumers and advocates, cannabis is completely “distrinct from tobacco” in that it is not associated with either lung cancer, or Chronic Obstructive Pulmonary Disease (COPD). More information on this study can be found by clicking here.
Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website. The final goal is to introduce medicinal cannabis products to the pharmaceutical drug market. This means that U.S.
The grant comes from Michigan’s 2021 Veteran Marijuana Research Grant Program , and is funded by the state’s recreational cannabis taxes. With a goal of determining the “the efficacy of marijuana in treating the medical conditions of United States armed services veterans and preventing veteran suicide.”. MAPS Makes History.
Make this year about you by taking the first step: finally getting your medical marijuana card. What is medical marijuana? Medical marijuana is the use of the marijuana plant or its chemicals to treat various diseases or conditions. What conditions is medical marijuana helpful for? Chronic pain. Multiple sclerosis.
It’s titled Medical marijuana certification for patients with sickle cell disease: A report of a single center experience. They found that “The patients who obtained medical marijuana showed a reduction in median six-month hospital admissions compared with the patients who … did not obtain medical marijuana.”
Data collected from MAPS-sponsored Phase 3 clinicaltrials suggests that MDMA-assisted therapy appears promising in the treatment of TBI. The grant comes from Michigan’s 2021 Veteran Marijuana Research Grant Program , and is funded by the state’s recreational cannabis taxes.
He noted, “The data in the study isn’t really ready for translation to the clinic.” More preclinical research involving cell cultures and animal models are needed, even before human clinicaltrials can take place to confirm the effects of cannabinoid acids on COVID infection. Where can you buy CBGA?
It’s a major precept of Judaism—and it’s also the name of Israel’s most prominent medical- marijuana company, now planting seeds around the globe. Tikun Olam , which was founded in 2007, controls nearly 40% of the Israeli medical-marijuana market. In the United States, it already has retail outposts in Nevada and Delaware. .
This year, we are completing the second Phase 3 clinicaltrial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. Members of Congress voiced support for marijuana/AIDS research. Rick Doblin, Ph.D., and Michael Mithoefer, M.D.,
THC is by far the most abundant and popular molecule in marijuana. However, the scientific data on CBG is nowhere near as developed as what we have on CBD. In 2018, the US government passed the Farm Bill, which excluded hemp from the definition of marijuana plants, which remain illegal under federal law. Easy access.
19 that correlates cannabis use with slightly elevated risk of metabolic syndrome (MetS) is inconsistent with previous research into the relationship between marijuana and related risk factors, such as elevated blood sugar levels and obesity. A study published by the Journal of Addiction Research and Therapy on Feb.
.” However, as noted by NORML, around half of respondents “expressed discomfort in talking to their patients about medical cannabis options, a finding that is also consistent with prior data. Many expressed a desire to receive additional education about cannabis in order to become better versed in the subject.”
To understand the breadth of issues and gather data on safety we have conducted a public hearing, reviewed the medical literature, and have an open public docket.”. The FDA is collecting data to fill these gaps. Governor Andrew Cuomo of New York, for example, in July of 2019, signed into law a bill decriminalizing marijuana.
Marijuana use is associated with a reduction in the use of attention-deficit hyperactivity disorder (ADHD) medications in patients diagnosed with the syndrome, according a new study published in the journal Rambam Maimonides and first reported on by NORML.
Nabiximol is a cannnabis derived drug that exited clinicaltrials in Spain. Various chemicals in marijuana effect the immune system in different ways. As more people take cannabinoids for approved nausea, vomiting, and approved uses, the data on the effects that they have on cancer can supplement research and clinicaltrials.
It’s a distant relative of marijuana. While more data is needed to confirm all these, its effects on our physical bodies show promise so far. This was when clinicaltrials found a significant reduction in seizures for people who took CBD. Alleviates Seizures.
Marijuana policies in the United States have become more permissive, motivating research on demographic and policy-based differences in behaviors and attitudes towards driving after marijuana use. The Traffic Safety Culture Index is an annual survey with national scope and multiple measures relevant to driving after marijuana use.
Numerous trials have been run using medical marijuana and CBD tinctures to treat or reduce the symptoms of Parkinson’s Disease. This is not the first medicinal trial of its kind. The effects were so promising that Parkinson’s UK began funding for the worlds first clinicaltrial. This trial was to take 3.5
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content